Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Appointed director
CC transcript
Appointed CFO

GILEAD SCIENCES, INC. (GILD) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/01/2018 BW Gilead Sciences Announces First Quarter 2018 Financial Results
04/17/2018 BW Gilead Sciences to Release First Quarter 2018 Financial Results on Tuesday, May 1, 2018
02/06/2018 BW Gilead Sciences Announces Fourth Quarter and Full Year 2017 Financial Results
01/23/2018 BW Gilead Sciences to Release Fourth Quarter and Full Year 2017 Financial Results on Tuesday, February 6, 2018
12/21/2017 BW Gilead Sciences to Present at the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8
10/26/2017 BW Gilead Sciences Announces Third Quarter 2017 Financial Results
10/12/2017 BW Gilead Sciences to Release Third Quarter 2017 Financial Results on Thursday, October 26, 2017
09/05/2017 BW Gilead Sciences to Present at the Morgan Stanley Global Healthcare Conference on Monday, September 11
09/01/2017 BW Gilead Sciences to Present at Citi's 12th Annual Biotech Conference on Wednesday, September 6
07/26/2017 BW Gilead Sciences Announces Second Quarter 2017 Financial Results
07/12/2017 BW Gilead Sciences to Release Second Quarter 2017 Financial Results on Wednesday, July 26, 2017
06/01/2017 BW Gilead Sciences to Present at the Goldman Sachs 38th Annual Global Healthcare Conference on Thursday, June 15
05/30/2017 BW Gilead Sciences to Present at the 37th Annual William Blair Growth Stock Conference on Tuesday, June 13
05/02/2017 BW Gilead Sciences Announces First Quarter 2017 Financial Results
04/18/2017 BW Gilead Sciences to Release First Quarter 2017 Financial Results on Tuesday, May 2, 2017
02/08/2017 BW Gilead Sciences to Present at the RBC Capital Markets 2017 Global Healthcare Conference on Wednesday, February 22
02/07/2017 BW Gilead Sciences Announces Fourth Quarter and Full Year 2016 Financial Results
08/15/2011 BW Gilead's Investigational Antiretroviral Quad Regimen Meets 48-Week Primary Objective in Pivotal Phase 3 Clinical Study 102
07/20/2011 BW Gilead's Investigational Antiretroviral Elvitegravir Once Daily Non-Inferior to Raltegravir Twice Daily at 48 Weeks
07/19/2011 BW Gilead Sciences to Release Second Quarter 2011 Financial Results on Tuesday, July 26, 2011
07/12/2011 BW Gilead Expands Access Program for Medications in Developing World
06/28/2011 BW Gilead Sciences Announces Agreement With Tibotec Pharmaceuticals to Develop and Commercialize a New Fixed-Dose Combination of Cobicistat and Prezista®
06/08/2011 BW Gilead Sciences to Present at the 31st Annual William Blair & Company Growth Stock Conference on Wednesday, June 15
05/31/2011 BW Gilead Sciences to Present at Two Upcoming Investor Conferences
04/29/2011 BW Gilead Sciences to Present at the Deutsche Bank 36th Annual Health Care Conference on Tuesday, May 3
04/27/2011 BW Gilead Appoints Dr. Muzammil M. Mansuri as Senior Vice President, Research and Development Strategy and Corporate Development
04/20/2011 BW Gilead Sciences Announces First Quarter 2011 Financial Results
04/20/2011 BW Gilead and MicroDose Therapeutx Announce License and Collaboration Agreement to Develop MDT-637 for Treatment of Respiratory Syncytial Virus
04/13/2011 BW Gilead Sciences to Release First Quarter 2011 Financial Results on Wednesday, April 20, 2011
03/30/2011 BW Yale and Gilead Sciences Announce Cancer Research Collaboration
03/23/2011 BW Gilead Prices $1 Billion of Senior Unsecured Notes
03/23/2011 BW Gilead to Offer Senior Notes
03/23/2011 BW Phase III Clinical Trial of Gilead's Investigational Elvitegravir Meets 48-Week Primary Objective
03/11/2011 BW Gilead Recommends Rejection of Mini-Tender Offer By TRC Capital Corporation
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy